I. Risk of Proposed Treatment:
I understand this authorization is given with the knowledge that the use of the appetite suppressants for more than 12 weeks and in higher doses than the dose indicated in the labeling involves some risks and hazards. The more common include: nervousness, sleeplessness, headaches, dry mouth, weakness, tiredness, psychological problems, medication allergies, high blood pressure, rapid heartbeat and heart irregularities. Less common, but more serious, risks are primary pulmonary hypertension and valvular heart disease, heart attack and stroke. Physical injury can result from such things as increased exercise and activity. GI side effects, such as constipation, diarrhea, and/or bloating, or development of gallbladder disease from rapid weight loss. These and other possible risks could, on occasion, be serious or fatal. Age may also be a factor in prescribing these medications and is at the discretion of the examining and treating physician. Phentermine has not been studied in patients older than 65 or younger than 18, therefore we cannot guarantee the safety or effectiveness of the medication in these age groups. Some patients may not be good candidates for prescription appetite suppressant use due to various medical reasons.
II. Risk of Proposed Treatment:
I understand this authorization is given with the knowledge that the use of the appetite suppressants for more than 12 weeks and in higher doses than the dose indicated in the labeling involves some risks and hazards. The more common include: nervousness, sleeplessness, headaches, dry mouth, weakness, tiredness, psychological problems, medication allergies, high blood pressure, rapid heartbeat and heart irregularities. Less common, but more serious, risks are primary pulmonary hypertension and valvular heart disease, heart attack and stroke. Physical injury can result from such things as increased exercise and activity. GI side effects, such as constipation, diarrhea, and/or bloating, or development of gallbladder disease from rapid weight loss. These and other possible risks could, on occasion, be serious or fatal. Age may also be a factor in prescribing these medications and is at the discretion of the examining and treating physician. Phentermine has not been studied in patients older than 65 or younger than 18, therefore we cannot guarantee the safety or effectiveness of the medication in these age groups.
Some patients may not be good candidates for prescription appetite suppressant use due to various medical reasons.
III. Risks Associated with Being Overweight or Obese:
I am aware that there are certain risks associated with remaining overweight or obese. Among them are tendencies to high blood pressure, to diabetes, to heart attack and heart disease, and to arthritis of the joints, hips, knees and feet, and many other diseases. Obesity and overweight also reduces my overall life expectancy. I understand these risks may be modest if I am not very much overweight but that these risks can go up significantly the more overweight I am. I recognize these current risks to my health as unacceptable and wish to aggressively treat my weight by enrolling in this program.
IV. No Guarantees:
I understand that much of the success of the program will depend on my efforts and that there are no guarantees or assurances that the program will be successful. I also understand that I will have to continue watching my weight all of my life if I am to be successful.
V. Patient’s Consent:
I have read and fully understand this consent form and I realize I should not sign this form if all items have not been explained, or any questions I have concerning them have not been answered to my complete satisfaction. I have been urged to take all the time I need in reading and understanding this form and in talking with my doctor regarding risks associated with the proposed treatment and regarding other treatments not involving the appetite suppressants.
I further understand that upon withdrawal from this program, I will not be entitled to a refund of any previously paid monies.